AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Founded Date:
N/A
Investor Type:
N/A
Employee Number:
N/A
Investment Stage:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Technology:
COVID
Industry:
Vaccine/Drug
Headquarters:
Denmark